Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 9, 2003
Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation
Donna M Wilcock, Giovanni DiCarlo, Debbi Henderson, et al.
Neurobiology of Aging
|
June 19, 2016
Metabolic changes over the course of aging in a mouse model of tau deposition
Aurélie Joly-Amado, Karisa S Serraneau, Milene Brownlow, et al.
Journal of Neuroinflammation
|
September 13, 2011
Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence
Donna M Wilcock, Dave Morgan, Marcia N Gordon, et al.
Journal of Neurochemistry
|
December 24, 2003
Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice
Chad A Dickey, Marcia N Gordon, Jerimiah E Mason, et al.
ASN Neuro
|
October 15, 2011
Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses
Donna M Wilcock, Qun Zhao, Dave Morgan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 12, 2017
Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice
Niki C Carty, Kevin Nash, Daniel Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 31, 2008
Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice
Niki C Carty, Kevin Nash, Daniel Lee, et al.
Research Square
|
June 3, 2024
Validation of a functional human AD model with four AD therapeutics utilizing patterned iPSC-derived cortical neurons integrated with microelectrode arrays
Julbert Caneus, Kaveena Autar, Nesar Akanda, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
July 9, 2008
Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice
Rachel A Karlnoski, Arnon Rosenthal, Jennifer Alamed, et al.
Neuro-Degenerative Diseases
|
July 17, 2012
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Maj-Linda B Selenica, Milene Brownlow, Jeffy P Jimenez, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 9, 2003
Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation
Donna M Wilcock, Giovanni DiCarlo, Debbi Henderson, et al.
Neurobiology of Aging
|
June 19, 2016
Metabolic changes over the course of aging in a mouse model of tau deposition
Aurélie Joly-Amado, Karisa S Serraneau, Milene Brownlow, et al.
Journal of Neuroinflammation
|
September 13, 2011
Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence
Donna M Wilcock, Dave Morgan, Marcia N Gordon, et al.
Journal of Neurochemistry
|
December 24, 2003
Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice
Chad A Dickey, Marcia N Gordon, Jerimiah E Mason, et al.
ASN Neuro
|
October 15, 2011
Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses
Donna M Wilcock, Qun Zhao, Dave Morgan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 12, 2017
Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice
Niki C Carty, Kevin Nash, Daniel Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 31, 2008
Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice
Niki C Carty, Kevin Nash, Daniel Lee, et al.
Research Square
|
June 3, 2024
Validation of a functional human AD model with four AD therapeutics utilizing patterned iPSC-derived cortical neurons integrated with microelectrode arrays
Julbert Caneus, Kaveena Autar, Nesar Akanda, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
July 9, 2008
Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice
Rachel A Karlnoski, Arnon Rosenthal, Jennifer Alamed, et al.
Neuro-Degenerative Diseases
|
July 17, 2012
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Maj-Linda B Selenica, Milene Brownlow, Jeffy P Jimenez, et al.
Page
of 9